Shawn Tomasello is of Allovir, Inc.. Currently has a direct ownership of 70,000 shares of ALVR, which is worth approximately $39,900. The most recent transaction as insider was on Jun 06, 2024, when has been sold 35,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70K
0% 3M change
100.0% 12M change
Total Value Held $39,900

Shawn Tomasello Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
35,000 Added 33.33%
70,000 Common Stock
May 11 2023
BUY
Grant, award, or other acquisition
-
35,000 Added 50.0%
35,000 Common Stock

Also insider at

FDMT
4D Molecular Therapeutics, Inc. Healthcare
URGN
UroGen Pharma Ltd. Healthcare
TCRR
TCR2 THERAPEUTICS INC. Healthcare
GMDA
Gamida Cell Ltd. Healthcare
CABA
Cabaletta Bio, Inc. Healthcare
ST

Shawn Tomasello

Cambridge, MA

Track Institutional and Insider Activities on ALVR

Follow Allovir, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALVR shares.

Notify only if

Insider Trading

Get notified when an Allovir, Inc. insider buys or sells ALVR shares.

Notify only if

News

Receive news related to Allovir, Inc.

Track Activities on ALVR